PREDICTION OF ANTIPSYCHOTIC ASSOCIATED WEIGHT GAIN IN CHILDREN AND ADOLESCENTS TAKING SECOND GENERATION ANTIPSYCHOTICS: A MACHINE LEARNING APPROACH

被引:0
|
作者
Lyu, N. [1 ]
Lin, Y. [2 ]
Rowan, P. J. [3 ]
Abughosh, S. M. [1 ]
Varisco, T. [1 ]
Chen, H. [1 ]
机构
[1] Univ Houston, Coll Pharm, Houston, TX USA
[2] Univ Houston, Cullen Coll Engn, Houston, TX USA
[3] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
MSR98
引用
收藏
页码:S278 / S278
页数:1
相关论文
共 50 条
  • [31] Weight Gain Associated with Atypical Antipsychotic Use in Children and Adolescents: Prevalence, Clinical Relevance, and Management
    Stigler K.A.
    Potenza M.N.
    Posey D.J.
    McDougle C.J.
    Pediatric Drugs, 2004, 6 (1) : 33 - 44
  • [32] Overdoses and ingestions of second-generation antipsychotics in children and adolescents
    Antia, SX
    Sholevar, EH
    Baron, DA
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2005, 15 (06) : 970 - 985
  • [33] Metabolic risk after six months of treatment with second-generation antipsychotics in antipsychotic-naive children and adolescents
    Diaz-Caneja, C. M.
    Giraldez-Quiroga, M.
    Merchan-Naranjo, J.
    Pina-Camacho, L.
    Tapia-Casellas, C.
    Rodriguez-Latorre, P.
    Arango, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S71 - S72
  • [34] Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain
    Grajales, Diana
    Ferreira, Vitor
    Valverde, Angela M.
    CELLS, 2019, 8 (11)
  • [35] Metformin (Met) Prevents Weight Gain in Youth on Second Generation Antipsychotics (SGA)
    Klein, David J.
    Khoury, Jane C.
    Marsolo, Keith
    Sorter, Michael
    Hornung, Lindsay
    Dolan, Lawrence M.
    DIABETES, 2013, 62 : A549 - A550
  • [36] Role of leptin and adiponectin in weight gain related to second-generation antipsychotics
    Alvarez Blazquez, M.
    Gonzalez-Vioque, E.
    Fraguas, D.
    Del Rey-Mejias, A.
    Pina-Camacho, L.
    Arango, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S16 - S17
  • [37] Patient, Treatment, and Health Care Utilization Variables Associated with Adherence to Metabolic Monitoring Practices in Children and Adolescents Taking Second-Generation Antipsychotics
    Coughlin, Mary
    Goldie, Catherine Lindsay
    Tranmer, Joan
    Khalid-Khan, Sarosh
    Tregunno, Deborah
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2018, 63 (04): : 240 - 249
  • [38] Short-term weight gain in antipsychotic-naive pediatric and adult patients with psychosis treated with second-generation antipsychotics
    Roventa, C.
    Diaz-Caneja, C. M.
    Pina-Camacho, L.
    Fraguas, D.
    Saiz, P. A.
    Corripio, I.
    Rodriguez-Jimenez, R.
    Gonzalez-Pinto, A.
    Sanjuan, J.
    Garcia-Lopez, A.
    Arias, B.
    Baeza, I.
    Alda, J. A.
    Martinez-Cantarero, C.
    Merchan-Naranjo, J.
    Arango, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S570 - S570
  • [39] Weight gain and metabolic changes in antipsychotic-naive young people after twelve months of treatment with second generation antipsychotics.
    Leganes Pastor, P. A.
    Diaz-Caneja, C. M.
    Andreu-Bernabeu, A.
    Pina-Camacho, L.
    Fraguas, D.
    Merchan Naranjo, J.
    Castro-Fornieles, J.
    Baeza Pertegaz, M. I.
    De la Serna Gomez, E.
    Martinez-Cantarero, C.
    Alda Diez, J. A.
    Arango Lopez, C.
    EUROPEAN PSYCHIATRY, 2018, 48 : S330 - S330
  • [40] Link among PPAR interaction with second generation antipsychotics, weight gain and lipid metabolism disruption - An in silico approach
    Homem-de-Mello, M.
    Braga, L. Dayane Carvalho Filiu
    Ribeiro Fontes, P.
    Nascimento Silva, A.
    Oliveira Magalhaes, P.
    TOXICOLOGY LETTERS, 2015, 238 (02) : S316 - S316